Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUN.TA)
ILA 38.4
(12.61%)
ILA 38.4
(12.61%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -88.88 Million ILS | -84.28% |
| 2022 | -48.23 Million ILS | -47.73% |
| 2021 | -32.65 Million ILS | 0.88% |
| 2020 | -32.94 Million ILS | -202.54% |
| 2019 | -10.88 Million ILS | 48.58% |
| 2018 | -21.17 Million ILS | -4701.13% |
| 2017 | -441 Thousand ILS | 51.11% |
| 2016 | -902 Thousand ILS | 68.12% |
| 2015 | -2.82 Million ILS | 31.1% |
| 2014 | -4.1 Million ILS | 69.3% |
| 2013 | -13.37 Million ILS | 33.71% |
| 2012 | -20.17 Million ILS | -192.63% |
| 2011 | 21.78 Million ILS | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -14.34 Million ILS | -34.26% |
| 2024 Q2 | -14.34 Million ILS | 0.0% |
| 2023 Q4 | -10.68 Million ILS | 0.0% |
| 2023 FY | -88.88 Million ILS | -84.28% |
| 2023 Q2 | -33.76 Million ILA | 0.0% |
| 2023 Q3 | -10.68 Million ILS | 68.36% |
| 2023 Q1 | -33.76 Million ILS | -72.31% |
| 2022 Q2 | -4.52 Million ILA | 0.0% |
| 2022 Q4 | -19.59 Million ILA | 0.0% |
| 2022 FY | -48.23 Million ILS | -47.73% |
| 2022 Q1 | -4.52 Million ILS | 49.42% |
| 2022 Q3 | -19.59 Million ILS | -332.98% |
| 2021 Q2 | -7.38 Million ILS | 0.0% |
| 2021 Q1 | -7.38 Million ILS | 27.61% |
| 2021 FY | -32.65 Million ILS | 0.88% |
| 2021 Q3 | -8.94 Million ILS | -21.21% |
| 2021 Q4 | -8.94 Million ILS | 0.0% |
| 2020 Q4 | -10.19 Million ILS | 0.0% |
| 2020 FY | -32.94 Million ILS | -202.54% |
| 2020 Q2 | -6.27 Million ILS | 0.0% |
| 2020 Q3 | -10.19 Million ILS | -62.44% |
| 2020 Q1 | -6.27 Million ILS | -64.59% |
| 2019 Q1 | -1.63 Million ILS | 84.24% |
| 2019 Q2 | -1.63 Million ILS | 0.0% |
| 2019 FY | -10.88 Million ILS | 48.58% |
| 2019 Q3 | -3.81 Million ILS | -133.78% |
| 2019 Q4 | -3.81 Million ILS | 0.0% |
| 2018 Q2 | -237.5 Thousand ILS | 0.0% |
| 2018 Q4 | -10.34 Million ILS | 0.0% |
| 2018 Q3 | -10.34 Million ILS | -4257.47% |
| 2018 Q1 | -237.5 Thousand ILS | 0.0% |
| 2018 FY | -21.17 Million ILS | -4701.13% |
| 2017 FY | -441 Thousand ILS | 51.11% |
| 2016 Q4 | -24 Thousand ILS | 96.16% |
| 2016 Q3 | -625 Thousand ILS | -1702.56% |
| 2016 FY | -902 Thousand ILS | 68.12% |
| 2016 Q2 | 39 Thousand ILS | 113.36% |
| 2016 Q1 | -292 Thousand ILS | 63.22% |
| 2015 Q1 | -2.18 Million ILS | -37.78% |
| 2015 Q4 | -794 Thousand ILS | -1.79% |
| 2015 Q3 | -780 Thousand ILS | -183.6% |
| 2015 Q2 | 933 Thousand ILS | 142.64% |
| 2015 FY | -2.82 Million ILS | 31.1% |
| 2014 Q1 | -504 Thousand ILS | 80.09% |
| 2014 Q2 | -1.52 Million ILS | -203.17% |
| 2014 FY | -4.1 Million ILS | 69.3% |
| 2014 Q3 | -486 Thousand ILS | 68.19% |
| 2014 Q4 | -1.58 Million ILS | -226.75% |
| 2013 Q2 | -323 Thousand ILS | 96.69% |
| 2013 FY | -13.37 Million ILS | 33.71% |
| 2013 Q4 | -2.53 Million ILS | -226.58% |
| 2013 Q1 | -9.74 Million ILS | 0.0% |
| 2013 Q3 | -775 Thousand ILS | -139.94% |
| 2012 FY | -20.17 Million ILS | -192.63% |
| 2011 FY | 21.78 Million ILS | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Cannabotech LTD | -16.12 Million ILA | -451.334% |